The Prevalence of Skin Cancer in Transplant Patients
Skin cancer is the most common cancer found in organ transplant recipients. Patients who have received organ transplants are at risk of developing skin cancer. Specifically, 65% more likely than people without transplants. Moreover, in a study conducted by the International Transplant Skin Cancer Collaborative (ITSCC), it was found that transplant patients have a 100-fold […]
States With The Highest Risk for Melanoma
This is taken from an article posted on CNN.com written by Shelby Lin Erdman dated 02/18/2020: (CNN) – States with the highest rates of melanoma cases linked to ultraviolet radiation are spread across the United States on the East and West coasts, in Hawaii and in landlocked states, according to a study published Monday in […]
Non-Melanoma Skin Cancer Outcomes
Dr. William Roth presents three cases of non-melanoma skin cancer being treated by Superficial Radio Therapy (SRT). Look at these amazing results!
Keloid Patient Testimonials
Hear from the patients themselves! These individuals had their keloids treated with SRT and have achieved amazing results.
Non-Melanoma Skin Cancer Patient Testimonials
Hear from the patients themselves! These individuals had their non-melanoma skin cancer treated with SRT and have achieved amazing results.
Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results
Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results […]
Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020
BOCA RATON, Fla. , Feb. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth […]
